WO2011001402A3 - Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain - Google Patents

Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain Download PDF

Info

Publication number
WO2011001402A3
WO2011001402A3 PCT/IB2010/053017 IB2010053017W WO2011001402A3 WO 2011001402 A3 WO2011001402 A3 WO 2011001402A3 IB 2010053017 W IB2010053017 W IB 2010053017W WO 2011001402 A3 WO2011001402 A3 WO 2011001402A3
Authority
WO
WIPO (PCT)
Prior art keywords
inactivating
pathogen
human blood
blood plasma
plasma sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2010/053017
Other languages
English (en)
Other versions
WO2011001402A2 (fr
Inventor
Gérard Demazeau
Nolwennig Rivalain
Alain Largeteau
Jean Roquain
Jean-Michel Boiron
Jean-Paul Maurel
Zoran Ivanovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Victor Segalen Bordeaux 2
Universite Sciences et Technologies Bordeaux 1
Etablissement Francais du Sang
Original Assignee
Universite Victor Segalen Bordeaux 2
Universite Sciences et Technologies Bordeaux 1
Etablissement Francais du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Victor Segalen Bordeaux 2, Universite Sciences et Technologies Bordeaux 1, Etablissement Francais du Sang filed Critical Universite Victor Segalen Bordeaux 2
Priority to BR112012000018-7A priority Critical patent/BR112012000018A2/pt
Priority to EP10740318A priority patent/EP2448601A2/fr
Priority to CN2010800377845A priority patent/CN102762231A/zh
Publication of WO2011001402A2 publication Critical patent/WO2011001402A2/fr
Anticipated expiration legal-status Critical
Publication of WO2011001402A3 publication Critical patent/WO2011001402A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A61L2103/09—Blood or products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention se rapporte à un procédé d' inactivation d'au moins un agent pathogène d'un échantillon de plasma sanguin humain comprenant la compression adiabatique dudit échantillon d'une pression Po à une pression P1, P1 étant comprise de 190 à 210 MPa, la température dudit plasma à la pression P1 étant compris entre - 10 °C et - 3 °C du fait de la compression, le maintien éventuel de la pression PI durant un temps compris entre 110 et 130 secondes, et la détente adiabatigue de l'échantillon. La présente invention se rapporte également à l'utilisation du procédé de l'invention et au plasma obtenu par le procédé de l'invention. Le procédé et les produis obtenus par ce procédé trouvent notamment des applications dans les domaines thérapeutiques et non thérapeutiques.
PCT/IB2010/053017 2009-07-03 2010-07-01 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain Ceased WO2011001402A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BR112012000018-7A BR112012000018A2 (pt) 2009-07-03 2010-07-01 processo de inativação de, pelo menos, um agente patogênico em uma amostra de plasma sanguíneo humano.
EP10740318A EP2448601A2 (fr) 2009-07-06 2010-07-01 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain
CN2010800377845A CN102762231A (zh) 2009-07-03 2010-07-01 对人血浆样品中的至少一种病原体灭活的方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0903292 2009-07-03
FR0903292A FR2947456B1 (fr) 2009-07-06 2009-07-06 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain

Publications (2)

Publication Number Publication Date
WO2011001402A2 WO2011001402A2 (fr) 2011-01-06
WO2011001402A3 true WO2011001402A3 (fr) 2015-11-19

Family

ID=41716536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/053017 Ceased WO2011001402A2 (fr) 2009-07-03 2010-07-01 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain

Country Status (5)

Country Link
EP (1) EP2448601A2 (fr)
CN (1) CN102762231A (fr)
BR (1) BR112012000018A2 (fr)
FR (1) FR2947456B1 (fr)
WO (1) WO2011001402A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104174042A (zh) * 2014-08-29 2014-12-03 郑州飞龙医疗设备有限公司 对生物制品中病原体的超高压灭活方法和应用
ITUB20156019A1 (it) * 2015-11-30 2017-05-30 Biocompatibility Innovation Soc A Responsabilita Limitata Semplificata Metodo per l'inattivazione di xenoantigeni in tessuti biologici

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048641A1 (fr) * 1998-06-15 2000-08-24 Bbi Bioseq, Inc. Sterilisation cryogenique rapide et preparation de vaccin
WO2002056824A2 (fr) * 2000-08-10 2002-07-25 Boston Biomedica, Inc. Inactivation de cycles de pression d'agents pathogenes dans des materiaux biologiques utilises pour des agents therapeutiques ou des vaccins
US20040151620A1 (en) * 1998-06-15 2004-08-05 Bbi Bioseq, Inc., A Massachusetts Corporation Rapid sterilization and vaccine preparation
JP2009082729A (ja) * 2008-11-18 2009-04-23 Bbi Bioseq Inc 迅速なクリオバリック滅菌及びワクチン調製

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536424A (ja) * 1999-02-13 2002-10-29 ピュアパルス テクノロジーズ インコーポレイテッド 広域スペクトルのパルス光を使用して病原体を不活性化する方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048641A1 (fr) * 1998-06-15 2000-08-24 Bbi Bioseq, Inc. Sterilisation cryogenique rapide et preparation de vaccin
US20040151620A1 (en) * 1998-06-15 2004-08-05 Bbi Bioseq, Inc., A Massachusetts Corporation Rapid sterilization and vaccine preparation
WO2002056824A2 (fr) * 2000-08-10 2002-07-25 Boston Biomedica, Inc. Inactivation de cycles de pression d'agents pathogenes dans des materiaux biologiques utilises pour des agents therapeutiques ou des vaccins
JP2009082729A (ja) * 2008-11-18 2009-04-23 Bbi Bioseq Inc 迅速なクリオバリック滅菌及びワクチン調製

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
D.W. BRADLEY , R.A. HESS , F. TAO , L. SCIABA-LENTZ , A.T. REMALEY , J.A. LAUGHARN JR. AND M. MANAK: "Pressure cycling technology:a novel approach to virus inactivation in plasma", TRANSFUSION, vol. 40, no. 2, February 2000 (2000-02-01), pages 193 - 200, XP002571157, ISSN: 0041-1132, DOI: 10.1046/j.1537-2995.2000.40020193.x *
HASHIZUME C ET AL: "KINETIC ANALYSIS OF YEAST INACTIVATION BY HIGH PRESSURE TREATMENT AT LOW TEMPERATURES", BIOSCIENCE BIOTECHNOLOGY BIOCHEMISTRY, JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY, TOKYO, JAPAN, vol. 59, no. 8, 1 August 1995 (1995-08-01), pages 1455 - 1458, XP000530302, ISSN: 0916-8451 *

Also Published As

Publication number Publication date
WO2011001402A2 (fr) 2011-01-06
CN102762231A (zh) 2012-10-31
FR2947456B1 (fr) 2012-03-09
BR112012000018A2 (pt) 2019-09-24
EP2448601A2 (fr) 2012-05-09
FR2947456A1 (fr) 2011-01-07

Similar Documents

Publication Publication Date Title
EA201101523A1 (ru) Способы лечения метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
WO2010091376A3 (fr) Dispositifs et procédé de traitement par perfusion
WO2009082433A3 (fr) Méthode de cryoablation au spray
WO2013040078A3 (fr) Tissus artificiels pour des utilisations en recherche in vitro, puces de ces tissus et procédés de fabrication correspondants
EP4406950A3 (fr) Inhibiteur de lfa-1 et polymorphe de celui-ci
WO2012174276A3 (fr) Dispositif de compression
WO2010149798A3 (fr) Utilisation de polyols pour augmenter l'effet de refroidissement d'une substance refroidissante et mélanges refroidissants ayant un plus grand effet de refroidissement
WO2013096741A3 (fr) Organoïdes comprenant un échafaudage vasculaire placentaire repeuplé et décellularisé
WO2012116081A3 (fr) Procédés d'identification d'agents cosmétiques pour des compositions de soins de la peau
IN2012DN00352A (fr)
WO2012174239A3 (fr) Ingénierie tissulaire in situ autologue
WO2006015035A8 (fr) Composés utiles pour l'infection par hpv
WO2007125105A3 (fr) Activateurs de la glucokinase benzamidique
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
HU0700384D0 (en) Nanocomposites of synthetised hydrogeles prepared by polymerisation of n-isopropyl-acrylamide, acrylamide and acrylacid, process for preparation thereof and their use for preparation of osmotically active hydrogeles in tissue expanding expanders
WO2015023507A8 (fr) Procédé pour augmenter le volume d'expiration forcée chez des asthmatiques à l'aide de benralizumab
SI2373310T1 (sl) Nove spojine 4- (heterocikloalkil) benzen-1, 3- diola kot inhibitorji tirosinaze, postopek njihove priprave in njihova uporaba v humani medicini in tudi v kozmetiki
WO2010135521A3 (fr) Compositions et procédés pour le traitement et le diagnostic de la grippe
HK1219962A1 (zh) 人抗白细胞介素-32抗体
WO2011001402A3 (fr) Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain
EP2533752B8 (fr) Préparations pour stabiliser/élaborer la texture d'un tissu vivant comme la peau, et leurs applications
BRPI0914167A2 (pt) formas sólidas de (1r,2s,3r)-1-(2-(isoxa-zol-3-il)-1h-imidazol-4il) butano-1,2,3,4-tetraol e métodos de uso das mesmas
WO2014064609A3 (fr) Composition de plante médicinale pour la prévention et le traitement de maladies à médiation par le tnf-α
WO2014082185A3 (fr) Matière de sorption pour la sorption de molécules de gaz, en particulier le co2, dans des interventions chirurgicales minimalement invasives
WO2010057141A3 (fr) Inhibiteurs d’alphavirus et leurs utilisations

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080037784.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10740318

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2010740318

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010740318

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012000018

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012000018

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120102